Qube Research & Technologies (QRT)
NGNE icon

Qube Research & Technologies (QRT)’s Neurogene NGNE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,135
Closed -$187K – 3844
2024
Q2 		$187K Sell
5,135
-67,900
-93% -$2.39M ﹤0.01% 2444
2024
Q1 		$3.72M Buy
+73,035
New +$2.44M 0.01% 1400
2022
Q4 		– Sell
-1,219
Closed -$16K – 2825
2022
Q3 		$16K Sell
1,219
-157
-11% -$3.2K ﹤0.01% 2329
2022
Q2 		$28K Buy
+1,376
New +$33.6K ﹤0.01% 2216
2021
Q3 		– Sell
-819
Closed -$151K – 2590
2021
Q2 		$151K Buy
+819
New +$181K ﹤0.01% 1860

Other funds holding NGNE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NGNE Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Neurogene (NGNE) in Q3 2024, closing a stake of 5,135 shares — an estimated $187K sold.

Qube Research & Technologies (QRT) first reported a position in NGNE in Q2 2021 and held it in 5 quarters. The position peaked at $3.72M in Q1 2024. 86 funds tracked by Wall St. Rank hold NGNE as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Neurogene position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 5,135 Neurogene shares in Q3 2024, an estimated $187K.
  • Qube Research & Technologies (QRT) first reported a position in Neurogene in Q2 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Neurogene position peaked at $3.72M in Q1 2024.
  • 86 funds tracked by Wall St. Rank held Neurogene as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.